Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

BACKGROUND: Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation receiving rivaroxaban and estimated the impact of r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://ncbi.nlm.nih.gov/pubmed/32079476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009530
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky